Seroreactivity to SARS-CoV-2 in individuals attending a university campus in Bogotá, Colombia
PDF

How to Cite

Gonzalez, J. M., Santos-Barbosa, J. C., Jaller, C., Otalora, G., Hernández, L. J., Guevara-Suárez, M., & Restrepo , S. (2022). Seroreactivity to SARS-CoV-2 in individuals attending a university campus in Bogotá, Colombia. Revista De La Academia Colombiana De Ciencias Exactas, Físicas Y Naturales, 46(178), 27–35. https://doi.org/10.18257/raccefyn.1590

Downloads

Download data is not yet available.

Métricas Alternativas


Dimensions

Abstract

Most community-specific serological surveys for SARS-CoV-2 antibodies have been performed in healthcare workers and institutions. In this study, IgG antibodies specific to the virus were evaluated in individuals working at a university campus in Bogotá, Colombia. Our aim was to determine previous exposure to SARS-CoV-2 in those attending the campus during city lockdown. A total of 237 individuals including 93 women and 144 men were evaluated using chemiluminescent detection of IgG anti-N-viral protein between November and December 2020. There were 32 positive individuals, i.e., a seroprevalence of 13.5% (10 women and 22 men) mostly asymptomatic (68.75%); we identified three clusters of seropositive individuals. Only 13 of the seropositive individuals had previous positive detection of SARS-CoV-2 RNA by RT-qPCR performed on average 91 days before the serological test. Seropositive individuals did not come from the boroughs with higher percentages of SARS-CoV-2 cases in the city. The survey was carried out after the first peak of SARS-CoV-2 transmission in the city and before the preparedness to reopen the campus for students in 2021, which demonstrates a low seroprevalence in a high percentage of asymptomatic individuals. These results will help to evaluate some of the strategies stablished to control virus spread on the campus or other similar communities. Key words: Coronavirus; SARS-CoV-2; Covid-19; serology.

https://doi.org/10.18257/raccefyn.1590

Keywords

Coronavirus | Serology | SARS-CoV-2 | Covid-19
PDF

References

Ariza, B., Torres, X., Salgado, D., Cepeda, M., Gómez Restrepo, C., Castellanos, J. C., Suárez-Obando, F., Cuellar, A., Cardozo, C., Ángel, J., Franco, M. A. (2021). Seroprevalence and seroconversion rates to SARS-COV-2 in interns, residents, and medical doctors in a University Hospital in Bogotá, Colombia. Infectio. 25 (3): 145. https://doi.org/10.22354/in.v25i3.938

Bobrovitz, N., Arora, R. K., Cao, C., Boucher, E., Liu, M., Donnici, C., Yanes-Lane, M., Whelan, M., Perlman-Arrow, S., Chen, J., Rahim, H., Ilincic, N., Segal, M., Duarte, N., Wyk, J. V., Yan, T., Atmaja, A., Rocco, S., Joseph, A. Cheng, M. P. (2021). Global seroprevalence of SARS-COV-2 antibodies: A systematic review and meta-analysis. PLoS One. 16(6):e0252617. doi: 10.1371/journal.pone.0252617.

Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S.I., Haupt, S., Frazier, A., Nakao, C., Rayaprolu, V., Rawlings, S. A., Peters, B., Krammer,F., Simon, V., Saphire, E. O., Smith, D. M., Weiskopf, D., Crotty, S. (2020). Immunological memory to SARS-COV-2 assessed for up to eight months after infection. Science. 371 (6529): eabf4063. doi: 10.1126/science.abf4063.

Ebrahim, S. H., Ahmed, Q. A., Gozzer, E., Schlagenhauf, P., Memish, Z. A. (2020). Covid-19 and community mitigation strategies in a pandemic. BMJ. m1066. https://doi.org/10.1136/bmj.m1066

González, J. M., Shelton, W. J., Díaz-Vallejo, M., Rodríguez-Castellanos, V. E., Zuluaga, J. D.,Chamorro, D. F., Arroyo-Ariza, D. (2020). Analysis of commercial assays for the detection of SARS-COV-2 antibodies or antigens. Open Journal of Immunology. 10 (02): 21–35.https://doi.org/10.4236/oji.2020.102003

Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F., Dela Cruz, C. S., Wang, Y., Wu, C., Xiao, Y., Zhang, L., Han, L., Dang, S., Xu, Y., Yang, Q.-W., Xu, S.-Y., Zhu, H.-D., Xu, Y.- C., Jin, Q., Wang, J. (2020). Profiling early humoral response to diagnose novel coronavirus disease (covid-19). Clinical Infectious Diseases. 71 (15): 778–785. https://doi.org/10.1093/cid/ciaa310

Houlihan, C. F., Vora, N., Byrne, T., Lewer, D., Kelly, G., Heaney, J., Gandhi, S., Spyer, M. J.,Beale, R., Cherepanov, P., Moore, D., Gilson, R., Gamblin, S., Kassiotis, G., McCoy, L.E., Swanton, C., Hayward, A., Nastouli, E., Aitken, J., Hatipoglu, E. (2020). Pandemic peak sars-COV-2 infection and seroconversion rates in London frontline health-care workers.The Lancet. 396 (10246). DOI: https://doi.org/10.1016/S0140-6736(20)31484-7

Instituto Nacional de Salud-INS. (2020). Covid-19 en Colombia. Coronavirus Colombia. Retrieved December 25, 2020, from https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx.

Instituto Nacional de Salud-INS. (2021). Estudio Nacional de Seroprevalencia. Accessed on: November 12, 2021. Available from: https://www.ins.gov.co/estudio-nacional-deseroprevalencia/reporte.html

Lisboa-Bastos, M., Tavaziva, G., Abidi, S. K., Campbell, J. R., Haraoui, L.-P., Johnston, J. C., Lan, Z., Law, S., MacLean, E., Trajman, A., Menzies, D., Benedetti, A., Ahmad Khan,

F. (2020). Diagnostic accuracy of serological tests for COVID-19: Systematic Review and meta-analysis. BMJ. m2516. https://doi.org/10.1136/bmj.m2516

Laiton-Donato, K., Villabona-Arenas, C., Usme-Ciro, J., Franco-Muñoz, C., Álvarez-Díaz, D., Villabona-Arenas, L., Echeverría-Londoño, S., Cucunubá, Z., Franco-Sierra, N., Flórez, A., Ferro, C., Ajami, N., Walteros, D., Prieto, F., Durán, C., Ospina-Martínez, M., Mercado-Reyes, M. (2020). Genomic epidemiology of SARS-CoV-2 in Colombia.medRxiv. 2020.06.26.20135715 https://doi.org/10.1101/2020.06.26.20135715

Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., Peck, L. J., Ritter, T. G., de Toledo, Z., Warren, L., Axten, D., Cornall, R. J., Jones, E. Y., Stuart, D. I., Screaton, G., Eyre, D. W.(2021). Antibody status and incidence of SARS-COV-2 infection in health care workers. New England Journal of Medicine. 384 (6): 533-540. https://doi.org/10.1056/nejmoa2034545

Mattar, S., Alvis-Guzmán, N., Garay, E., Rivero, R., García, A., Botero, Y., Miranda, J., Galeano, K., de La Hoz, F., Martínez, C., Arrieta, G., Faccini-Martínez, Á. A., Guzmán,

C., Kerguelen, H., Moscote, M., Contreras, H., & Contreras, V. (2020). Severe acute respiratory syndrome coronavirus 2 seroprevalence among adults in a tropical city of the Caribbean area, Colombia: Are we much closer to herd immunity than developed countries? Open Forum Infectious Diseases. 7 (12). https://doi.org/10.1093/ofid/ofaa550

Morawska, L. & Cao, J. (2020). Airborne transmission of SARS-COV-2: The world should face the reality. Environment International. 139: 105730. https://doi.org/10.1016/j.envint.2020.105730

Müller, L., Ostermann, P. N., Walker, A., Wienemann, T., Mertens, A., Adams, O., Andree, M., Hauka, S., Lübke, N., Keitel, V., Drexler, I., Di Cristanziano, V., Hermsen, D. F., Kaiser, R., Boege, F., Klein, F., Schaal, H., Timm, J., Senff, T. (2021). Sensitivity of anti-SARS-cov-2 serological assays in a high-prevalence setting. European Journal of Clinical Microbiology & Infectious Diseases. 40 (5): 1063-1071. https://doi.org/10.1007/s10096-021-04169-7

Oran, D. P. & Topol, E. J. (2021). The proportion of SARS-COV-2 infections that are asymptomatic. Annals of Internal Medicine. 174 (5): 655-662. https://doi.org/10.7326/m20-6976

Piec, I., English, E., Thomas, M. A., Dervisevic, S., Fraser, W. D., John, W. G. (2021). Performance of SARS-COV-2 serology tests: Are they good enough? PLOS ONE. 16 (2). https://doi.org/10.1371/journal.pone.0245914

Richmond, C. S., Sabin, A. P., Jobe, D. A., Lovrich, S. D., Kenny, P. A. (2020). SARS-COV-2 sequencing reveals rapid transmission from college student clusters resulting in morbidity and deaths in vulnerable populations. medRxiv 2020.10.12.20210294. https://doi.org/10.1101/2020.10.12.20210294

Roshan, R., Feroz, A. S., Rafique, Z., Virani, N. (2020). Rigorous hand hygiene practices among health care workers reduce hospital-associated infections during the COVID-19 pandemic. Journal of Primary Care & Community Health. 11: 215013272094333. https:// doi.org/10.1177/2150132720943331

Saludata. (2021). Datos en Salud Enfermedades transmisibles. Accessed on: March 28, 2021. Available from: https://saludata.saludcapital.gov.co/osb/index.php/datos-de-salud/enfermedadestrasmisibles/covid19/.

Shrock, E., Fujimura, E., Kula, T., Timms, R. T., Lee, I.-H., Leng, Y., Robinson, M. L., Sie, B.M., Li, M. Z., Chen, Y., Logue, J., Zuiani, A., McCulloch, D., Lelis, F. J., Henson, S., Monaco, D. R., Travers, M., Habibi, S., Clarke, W. A., Wong, C. (2020). Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science.370 (6520). https://doi.org/10.1126/science.abd4250

Universidad de los Andes. (2021). Universidad EN CIFRAS. Dirección de Planeación y Evaluación. Accessed on: February 8, 2021. Available from: https://planeacion.uniandes.edu.co/estadisticas/universidad-en-cifras

Walke, H. T., Honein, M. A., Redfield, R. R. (2020). Preventing and responding to COVID-19 on college campuses. JAMA. 324 (17): 1727. https://doi.org/10.1001/jama.2020.20027

Wilson, E., Donovan, C. V., Campbell, M., Chai, T., Pittman, K., Seña, A. C., Pettifor, A., Weber, D. J., Mallick, A., Cope, A., Porterfield, D. S., Pettigrew, E., Moore, Z. (2020). Multiple COVID-19 clusters on a university campus — North Carolina, August 2020. MMWR. Morbidity and Mortality Weekly Report. 69 (39): 1416–1418. https://doi.org/10.15585/mmwr.mm6939e3

World Health Organization-WHO. (2020). Diagnostic testing for SARS-COV-2. World Health Organization. Accessed on: March 25, 2021. Available from: https://www.who.int/publications-detail-redirect/diagnostic-testing-for-sars-cov-2

Xu, X., Sun, J., Nie, S., Li, H., Kong, Y., Liang, M., Hou, J., Huang, X., Li, D., Ma, T., Peng, J., Gao, S., Shao, Y., Zhu, H., Lau, J. Y.-N., Wang, G., Xie, C., Jiang, L., Huang, A., Hou, F. F. (2020). Seroprevalence of Immunoglobulin M and G antibodies against SARS-COV-2 in China. Nature Medicine. 26 (8): 1193-1195. https://doi.org/10.1038/s41591-020-0949-6

Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., Qian, S., Hong, C., Wang, F., Liu, Y., Wang, Z., He, Q., Li, Z., He, B., Zhang, T., Zhang, Z. (2020). Antibody responses to SARS-COV-2 in patients with novel coronavirus disease 2019. Clinical Infectious Diseases. 71 (16): 2027-2034. https://doi.org/10.1093/cid/ciaa344

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine. 382 (8): 727-733. https://doi.org/10.1056/nejmoa2001017

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2021 Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales